Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial

BACKGROUND: Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pathological lymph node excision, which must be marked by a reliable marker befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Žatecký, Jan, Coufal, Oldřich, Zapletal, Ondřej, Kubala, Otakar, Kepičová, Markéta, Faridová, Adéla, Rauš, Karel, Gatěk, Jiří, Kosáč, Peter, Peteja, Matúš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439625/
https://www.ncbi.nlm.nih.gov/pubmed/37596658
http://dx.doi.org/10.1186/s12957-023-03147-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439625/
https://www.ncbi.nlm.nih.gov/pubmed/37596658
http://dx.doi.org/10.1186/s12957-023-03147-x

Ejemplares similares